Category: Urticaria

DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS

Posted on | Posted on John Murphy | Leave a Comment on DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS

Originally published on The Lancet Infectious Disease KEY FINDINGS Study Methods In April 2020, working with the International League of Dermatological Societies and the American Academy of Dermatology, the researchers established an international registry for health care providers to report COVID-19 dermatologic signs and symptoms. Overall Duration of Signs/Symptoms Between April 8 and October 8, 2020, clinicians from 41 […]

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

Posted on | Posted on John Murphy | Leave a Comment on Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

Parnian Jamshidi, Bahareh Hajikhani, Mehdi Mirsaeidi, Hassan Vahidnezhad, Masoud Dadashi, Mohammad Javad Nasiri; Front. Med., 16 February 2021Sec. Infectious Diseases – Surveillance, Prevention and Treatment Volume 8 – 2021 | https://doi.org/10.3389/fmed.2021.634208 Introduction: Until now, there are several reports on cutaneous manifestations in COVID-19 patients. However, the link between skin manifestations and the severity of the disease remains debatable. We […]

Chronic Spontaneous Urticaria Following COVID-19 Vaccination: A Case Report and Discussion on Allergic Reactions and Vaccine Safety

Posted on | Posted on John Murphy | Leave a Comment on Chronic Spontaneous Urticaria Following COVID-19 Vaccination: A Case Report and Discussion on Allergic Reactions and Vaccine Safety

Jesus Ivan Martinez-Ortega1 and Felipe de Jesus Perez Hernandez2 Cureus. 2023 Sep; 15(9): e44860. Published online 2023 Sep 7. doi: 10.7759/cureus.44860 PMCID: PMC10560097 PMID: 37809203 Abstract This case report examines a rare occurrence of chronic spontaneous urticaria (CSU) following the administration of the CoronaVac vaccine for COVID-19. The patient developed persistent urticarial lesions that appeared and disappeared over an extended period after […]

Treatment Options ME/CFS

Posted on | Posted on John Murphy | Leave a Comment on Treatment Options ME/CFS

There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients with ME/CFS but not others. Other strategies, like learning new ways to manage activity, can also be helpful. Patients, their families, and healthcare providers need […]

Skin reactions to COVID-19 vaccines?  

Posted on | Posted on John Murphy | Leave a Comment on Skin reactions to COVID-19 vaccines?  

2020-January 18 The coronavirus disease 2019 (COVID-19) pandemic has led to the development and approval of vaccines against the responsible virus — severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More than 100 companies and institutions worldwide have developed vaccine candidates.  How do the COVID-19 vaccines differ? Current approved vaccines rely on a nucleic-acid-based vaccine platform Messenger ribonucleic acid (mRNA) eg, Pfizer/BioNTech + Fosun Pharma, Moderna + National Institute […]

Common Skin Signs of COVID-19 in Adults: An Update

Posted on | Posted on John Murphy | Leave a Comment on Common Skin Signs of COVID-19 in Adults: An Update

Five categories of cutaneous abnormalities are associated with COVID-19 By Samantha Polly, MD, and Anthony P. Fernandez, MD, PhD This article has been excerpted and reprinted (without references) from the Cleveland Clinic Journal of Medicine (2022, 89(3):161-167. The open-access and fully referenced original article is available here. As experience with caring for patients with COVID-19 has accumulated since the […]

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Posted on | Posted on John Murphy | Leave a Comment on Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

Devon E McMahon, Antonia E Gallman, George J Hruza, Misha Rosenbach, Jules B Lipoff, Seemal R Desai Published: January 15, 2021DOI:https://doi.org/10.1016/S1473-3099(20)30986-5 Lancet: VOLUME 21, ISSUE 3, P313-314, MARCH 2021 Since the start of the COVID-19 pandemic, multiple studies have reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with dermatological manifestations.  However, data on duration […]

Management of urticaria in COVID-19 patients: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on Management of urticaria in COVID-19 patients: A systematic review

Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands. There is now emerging evidence of patients experiencing urticaria. We sought to systematically review current evidence, critique the literature, and present our findings. Allowing PRISMA […]

COVID-19: Cutaneous manifestations and issues related to dermatologic care

Posted on | Posted on John Murphy | Leave a Comment on COVID-19: Cutaneous manifestations and issues related to dermatologic care

Authors: Steven R Feldman, MD, PhD, Esther E Freeman, MD, PhD Literature review current through: Jul 2021. | This topic last updated: Apr 06, 2021. INTRODUCTION Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), raises many critical issues in dermatology and dermatologic care. Addressing these issues is necessary, yet also challenging, because there are […]